And so MEDEN 2024 comes to a closure. See you next year in Lyon! Romain Marignier #NMOSD #MOGAD

Ohh so happy to learn that that this great effort is valued and helps the community to take decisions on #riskminimizationstrategie thank you ECTRIMS European Academy of Neurology Susana Otero Vukusic sandra christine lebrun frenay Cemcat MSJ

C’est parti !! La SEP expliquée aux enfants par le Réseau Rhone-Alpes SEP ! 🦜🦆🦉

Prof. Christine Lebrun-Frenay christine lebrun frenay, Head of Neurology at CHU de Nice, will be the Confavreux Lecturer at #ECTRIMS2024. Gain invaluable insights into radiologically isolated syndromes (RIS). 📅 20 September 📍 Copenhagen & online 🎫 Register here: bit.ly/42L7Z9g

Fantastic session on real world evidence - women are treated less in total and less effective ☹️Sandra Vukusic thanks for investigating in 🇫🇷 ….

Thank you Kerstin Hellwig for highlighting ! 🥰 hope we can raise awareness and change that rapidly in the future ! 💪ECTRIMS Antoine Gavoille

🇭🇷🏆 WOW! Marin Cilic wins his first title in THREE YEARS! Record BROKEN: - Marin is the lowest ranked player EVER to win an ATP tour title (started the tournament as # 777) 🤯

Highlight? Getting the 🏆! 🥳- - other highlights: Mc Donald 2024- BTKI- therapeutic intertia in women with MS Sandra Vukusic and 🤰🤱data posters talks Ruth Dobson Celia Oreja-Guevara and all others! 🎂ECTRIMS-40🥂!

Gracias Rafa, #RafaSiempre ❤️

Respect! 🥹

October 24th is Dr. Eugène Devic’s birthday. In 1894, French neurologist from Lyon, Dr. Devic & his student, Fernand Gault, described a rare nervous condition that affected the spinal cord & optic nerves that resembled #MS The disorder is now known as Devic's disease or #NMOSD

New article in the MSJ: A newly introduced JC virus assay classified 61.4% of MS patients as seropositive compared to just 23.6% with the reference test. The high rate of discrepancy challenges clinical decision-making. 🔗 Read the article here: bit.ly/4jZHGD5

Open for applications! The 4th ECTRIMS Winter School in January 2026 will focus on advances in the diagnosis and treatment of #NMOSD and #MOGAD. Learn more about the programme 👉 bit.ly/3SjqKwI Application deadline: 1 Sept 2025 #ECTRIMSNextGen #MSResearch

New Study Published in @greenjournal: Women less likely than men to receive #MS drugs. hubs.la/Q03zFdxQ0 #AANscience

Sclérose en plaques : des réticences médicales freinent l’accès des femmes à certains traitements. lequotidiendumedecin.fr/actu-medicale/…

New controversy available ⚖️ 📢High-risk populations should be screened for #MultipleSclerosis? 1/🧵

Neurologists should be aware of the most recent recommendations on the use of DMTs in pregnancy and breastfeeding ! Women living with MS should know they can become mothers safely ! 🤗 Please share widely ! 💪

Anti-CD20s are the most efficient strategy to prevent relapses in pregnancy and post-partum, followed by natalizumab used up to the end of second trimester and rapidly resumed. @ofsep

Want to attend a TSF Patient Day? Save the date for 2025 events below: 🇺🇸 Seattle, WA - October 18 (Registration is open: tinyurl.com/TSFSeattle) Shuvro Roy, MD 🇨🇦 Toronto - November 8 🇮🇹 Rome - November 22 Raffaele Iorio 🇫🇷 Lyon - November 29 Romain Marignier julie pique

The Sumaira Foundation Shuvro Roy, MD Raffaele Iorio julie pique Great programme for great cities ;)